| Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients (NCT05475665) | Handok Inc. | 2022-07-14 |
| Study to Evaluate and Compare the Efficacy and Safety of AZM and AML Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects (NCT05385770) | Celltrion | 2022-07-08 |
| Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients (NCT05476354) | Handok Inc. | 2022-07-05 |
| Efficacy and Safety of AJU-C52 in Essential Hypertension Patients (NCT06416865) | AJU Pharm Co., Ltd. | 2022-06-27 |
| A Multicenter, Randomized, Double-Blind Phase 3 Trial of KDF1901 in Patients With Essential Hypertension (NCT07116863) | Kyungdong Pharmaceutical Co., Ltd. | 2022-06-21 |
| Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension (NCT06282549) | Yuhan Corporation | 2022-06-08 |
| Evaluation of Black Chokeberry Bio Juice on Blood Pressure Levels and Endothelial Damage (NCT05912322) | University of Medicine and Pharmacy "Victor Babes" Timisoara | 2022-06-01 |
| Protective Effect of Beraprost Sodium Tablets on Reperfusion Therapy for Acute STEMI (NCT05103813) | Shenzhen People's Hospital | 2022-05-01 |
| Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension (NCT06212648) | Shin Poong Pharmaceutical Co. Ltd. | 2022-03-25 |
| A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China (NCT05638269) | Zhujiang Hospital | 2022-03-01 |
| Physical Activity, Air Pollution, and High Blood Pressure (NCT05092672) | University of British Columbia | 2021-11-15 |
| Juvenile Essential Arterial Hypertension and Vascular Function (NCT05109013) | Josip Juraj Strossmayer University of Osijek | 2021-09-01 |
| Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension (NCT05359068) | Shanghai Pharmaceuticals Holding Co., Ltd | 2021-06-10 |
| To Assess Allisartan Isoproxil/Amlodipine in Patients With Essential Hypertension Uncontrolled With Amlodipine or Allisartan Isoproxil (NCT06465264) | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 2021-04-29 |
| Water and Electrolytes Content in HYpertension (WHYSKI) in the SKIn (NCT06090617) | University Hospital Padova | 2021-01-01 |
| Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential Hypertension (NCT04554303) | Ahn-Gook Pharmaceuticals Co.,Ltd | 2020-10-28 |
| The Effect of the Use of BATHE Interview Technique on Treatment Compliance in Hypertension Patients in Primary Care (NCT05476120) | Dokuz Eylul University | 2020-10-01 |
| Repurposing Colchicine to Improve Vascular Function in Hypertension (NCT04303689) | University of Copenhagen | 2020-08-01 |
| s086 Tablets in the Treatment of Mild to Moderate Essential Hypertension (NCT05033535) | Shenzhen People's Hospital | 2020-07-01 |
| Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension (NCT04488978) | Handok Inc. | 2020-05-21 |
| Effect of Atorvastatin on Carotid Intima Media Thickness (NCT04306627) | Yerevan State Medical University | 2020-04-15 |
| Personal Activity Intelligence in the Treatment of High Blood Pressure (NCT04151537) | Norwegian University of Science and Technology | 2019-10-21 |
| A Study for PMS of AZL-M/CLD FDC in the Treatment of Participants With Essential HTN in South Korea (NCT04470830) | Celltrion Pharm, Inc. | 2019-09-11 |
| Heat Therapy in Older Hypertensive Women (NCT03857490) | University of Texas Southwestern Medical Center | 2019-07-29 |
| BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination (NCT03991442) | Boryung Pharmaceutical Co., Ltd | 2019-06-17 |
| Sympathetic Mapping/ Ablation of Renal Nerves Trial (SMART) HTN-OFF MED Study (NCT03885843) | The Second Affiliated Hospital of Chongqing Medical University | 2019-06-01 |
| LCZ696 in Advanced LV Hypertrophy and HFpEF (NCT03928158) | National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | 2019-05-31 |
| Effect of Breathing and Muscle Relaxation Technique in Individual With Essential Hypertension (NCT05684666) | King Saud University | 2019-02-21 |
| Effects of Aromatherapy in Hypertensive Individuals (NCT04460300) | Abant Izzet Baysal University | 2018-12-03 |
| Clinical Trial on Remote Ischemic Conditioning and Hypertension（HOPE） (NCT03566654) | Ji Xunming,MD,PhD | 2018-08-30 |
| A Study for PMS of AZL-M in the Treatment of Adult Participants With Essential Hypertension in South Korea (NCT04470817) | Celltrion Pharm, Inc. | 2018-08-07 |
| Vedic Medical Astrology in Essential Hypertension (NCT03803306) | NMP Medical Research Institute | 2018-07-12 |
| Evaluation of the Clinical Efficacy and Safety of Amlodipine 5mg/ Bisoprolol Fumarate 5mg /Perindopril Arginine 5mg Fixed-dose Combination in Capsule and Free Monotherapy at the Same Dose in Patients With Uncontrolled Essential Hypertension. (NCT05288400) | Servier | 2018-05-14 |
| Amlodipine VaLsartan Efficacy in Hypertensive Patients.A Real World Trial (NCT03371797) | PharmEvo Pvt Ltd | 2018-02-20 |
| Study MIPAE - Melatonin and Essential Arterial Hypertension (NCT05257291) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2018-02-02 |
| Effect of Aerobic Exercise in Patients With Essential Hypertension (NCT05987436) | TC Erciyes University | 2017-11-01 |
| An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension (NCT03514641) | Theracos | 2017-10-18 |
| Evaluation of a Transmedial Psychoeducational Program to Improve Pharmacological Adherence (NCT03924115) | Universidad de Concepcion | 2017-10-10 |
| Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia (NCT03156842) | Boryung Pharmaceutical Co., Ltd | 2017-05-29 |
| Prognostic Risk of Patients With Essential Hypertension for Cardiovascular Events (PROSPECT) (NCT03708601) | Beijing Institute of Heart, Lung and Blood Vessel Diseases | 2016-09-08 |
| Study of CS-3150 in Patients With Essential Hypertension (NCT02890173) | Daiichi Sankyo Co., Ltd. | 2016-09-01 |
| Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension (NCT02848170) | Daiichi Sankyo Co., Ltd. | 2016-08-01 |
| Safety Study of RMJH-111b to Treat Essential Hypertension (NCT02822222) | RMJ Holdings, LLC | 2016-06-10 |
| Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension (NCT02722265) | Daiichi Sankyo Co., Ltd. | 2016-03-01 |
| Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension (NCT02603809) | Idorsia Pharmaceuticals Ltd. | 2015-12-14 |
| S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension (NCT03226340) | Seoul National University Bundang Hospital | 2015-12-02 |
| Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure (NCT03063697) | Chong Kun Dang Pharmaceutical | 2015-11-01 |
| Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With Hypertension (NCT02480764) | Takeda | 2015-08-27 |
| Efficacy and Safety of Arotinolol Hydrochloride on Morning Blood Pressure and Heart Rate (NCT02612298) | Marubeni Pharmaceuticals (Suzhou) Co., Ltd. | 2015-08-01 |
| Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia (NCT02517866) | Takeda | 2015-07-13 |
| Observational Study of Efficacy and Safety of Nebivolol in Korean Patients With Essential Hypertension (NCT03847350) | A.Menarini Asia-Pacific Holdings Pte Ltd | 2015-07-01 |
| Fimasartan Achieving SBP Target (FAST) Study (NCT02495324) | Boryung Pharmaceutical Co., Ltd | 2015-06-01 |
| The Northwest Coalition for Primary Care Practice Support (NCT02839382) | Kaiser Permanente | 2015-05-01 |
| Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients (NCT02738632) | IlDong Pharmaceutical Co Ltd | 2015-05-01 |
| Treatment of HYpertension: Morning Versus Evening (NCT02214498) | Erasmus Medical Center | 2015-05-01 |
| Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension (NCT02322450) | Quantum Genomics SA | 2015-01-01 |
| A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects (NCT02345044) | Daiichi Sankyo | 2015-01-01 |
| Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension (NCT02407210) | Jiangsu HengRui Medicine Co., Ltd. | 2015-01-01 |
| Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure and Central Arterial Pressure (NCT02357615) | Shanghai Shyndec Pharmaceutical Co., Ltd. | 2014-12-01 |
| A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy (NCT02368652) | HK inno.N Corporation | 2014-12-01 |
| A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy (NCT02368665) | HK inno.N Corporation | 2014-12-01 |
| A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension (NCT02277691) | Takeda | 2014-11-07 |
| The Effects of Social Support and Oxytocin Administration on Physiological Stress Reactivity in Essential Hypertension (NCT01938911) | Insel Gruppe AG, University Hospital Bern | 2014-11-01 |
| The Effect of a Homoeopathic Complex on Blood Pressure in Refractory Hypertension (NCT02419235) | University of Johannesburg | 2014-10-01 |
| Evaluation of Stendo Pulsating Suit on Microcirculation and Central Blood Pressure in Essential Hypertension Patients (NCT02277821) | Stendo | 2014-10-01 |
| Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension (NCT02944734) | Shin Poong Pharmaceutical Co. Ltd. | 2014-09-01 |
| Microvascular Function in Primary Aldosteronism (NCT02096939) | Maastricht University Medical Center | 2014-09-01 |
| To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers (NCT02579356) | Samil Pharmaceutical Co., Ltd. | 2014-05-01 |
| Fimasartan/Amlodipine Combination Phase III (NCT02152306) | Boryung Pharmaceutical Co., Ltd | 2014-04-01 |
| A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension (NCT02206165) | Chong Kun Dang Pharmaceutical | 2014-03-01 |
| Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension (NCT02031861) | Shanghai Shyndec Pharmaceutical Co., Ltd. | 2014-02-01 |
| Study of Efficacy and Safety of CVAA489 in Hypertensive Patients (NCT02062645) | Novartis Pharmaceuticals | 2014-02-01 |
| A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension (NCT02059616) | HK inno.N Corporation | 2014-02-01 |
| PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension (NCT02058446) | TSH Biopharm Corporation Limited | 2013-10-01 |
| Helius in Hypertension-I: The UK Hypertension Registry (NCT02553512) | Proteus Digital Health, Inc. | 2013-09-01 |
| Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine (NCT01956786) | Shenzhen Ausa Pharmed Co.,Ltd | 2013-09-01 |
| GRK4 Polymorphisms Blood Pressure Response to Candesartan (NCT01629225) | Third Military Medical University | 2013-07-01 |
| Study of Personalized Dietary Intervention for the Control of Essential Hypertension (NCT02136264) | University of Nigeria, Enugu Campus | 2013-06-01 |
| Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomera™ (PB1046) in Adult Subjects With Stage 1 or 2 Essential Hypertension (NCT01873885) | PhaseBio Pharmaceuticals Inc. | 2013-06-01 |
| Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension (NCT02412761) | The University of Texas Health Science Center, Houston | 2013-06-01 |
| A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension (NCT01878201) | Boryung Pharmaceutical Co., Ltd | 2013-05-01 |
| Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy (NCT01838850) | Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo Company | 2013-04-01 |
| Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg (NCT01819870) | Chong Kun Dang Pharmaceutical | 2013-04-01 |
| Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine (NCT01842230) | Chong Kun Dang Pharmaceutical | 2013-04-01 |
| Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension (NCT01785472) | Novartis Pharmaceuticals | 2013-04-01 |
| Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin. (NCT01842256) | Chong Kun Dang Pharmaceutical | 2013-04-01 |
| Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine (NCT01848873) | Shenzhen Ausa Pharmed Co.,Ltd | 2013-01-01 |
| Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function (NCT01825759) | West China Hospital | 2013-01-01 |
| Study of the Product QGC001 as a Single Dose and Multiple Doses Administered Orally to Healthy Adult Subjects (NCT01900184) | Quantum Genomics SA | 2012-12-01 |
| Study of Myocardial Interstitial Fibrosis in Hyperaldosteronism (NCT02938910) | Assistance Publique - Hôpitaux de Paris | 2012-11-01 |
| Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to Amlodipine (NCT01663233) | Novartis Pharmaceuticals | 2012-08-01 |
| The Effects of Nebivolol on the NO-system in Patients With Essential Hypertension (NCT01679652) | Erling Bjerregaard Pedersen | 2012-08-01 |
| Effect of Acupuncture on Patients With Mild Hypertension (NCT01701726) | Chengdu University of Traditional Chinese Medicine | 2012-07-01 |
| Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension (NCT01599104) | Novartis Pharmaceuticals | 2012-06-01 |
| Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension (NCT01631227) | Abbott | 2012-06-01 |
| Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia (NCT01541943) | HanAll BioPharma Co., Ltd. | 2012-03-01 |
| Effect of Renal Denervation on NO-mediated Sodium Excretion and Plasma Levels of Vasoactive Hormones (NCT01617551) | Regional Hospital Holstebro | 2012-03-01 |
| Phase I Study in Healthy Male Subjects Comparing QGC001 to Placebo (NCT01900171) | Quantum Genomics SA | 2012-02-01 |
| Perindopril Amlodipine for the Treatment of Hypertension (NCT01556997) | Symplmed Pharmaceuticals LLC | 2012-02-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential Hypertension (NCT01523067) | PhaseBio Pharmaceuticals Inc. | 2012-01-01 |